In this study, we showed that UBE2C is an oncogenic protein in the lung, supported by association studies in human lung tumor tissues, in vitro cell culture gain- or loss-of-function studies using lung cancer cell lines harboring Kras mutations, and an in vivo conditional KO study using a KrasG12D mouse lung tumorigenesis model. This evidence concerns the gene KRAS and lung carcinoma.